CompaniesFunctional Neuromodulation

Functional Neuromodulation

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (5)
View all

Total Trials

5

As Lead Sponsor

4

As Collaborator

1

Total Enrollment

247

By Phase

NA: 4PHASE3: 1

By Status

COMPLETED: 4UNKNOWN: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Today
NCT01608061
NCT03622905
Hover over trial bars to see details

Recent Trials

NCT03622905Lead Sponsor
ADvance II Study: DBS-f in Patients With Mild Alzheimer's Disease
NACompleted
74 participants
Started: Aug 1, 2019 · Completed: Feb 19, 2024
NCT02738242Lead Sponsor
Evaluation of Usability and Human Factors in the Novus System
NAUnknown
16 participants
Started: May 31, 2016 · Completed: Jan 31, 2017
NCT02494323Lead Sponsor
Evaluation of Dual Channel vs. Single Channel FES for Dropfoot
NACompleted
70 participants
Started: Mar 31, 2015 · Completed: Jan 31, 2016
NCT01608061Lead Sponsor
ADvance DBS-f in Patients With Mild Probable Alzheimer's Disease
NACompleted
42 participants
Started: May 31, 2012 · Completed: Sep 30, 2018
NCT01237860Collaborator
Evaluation of the Safety and Performance of the NESS L300 Plus System
PHASE3Completed
45 participants
Started: Sep 30, 2010 · Completed: Jan 31, 2011